Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 85, Issue 5, 1998, Pages 558-564

  Hunter, Keith D ^a   Gibson, John ^a   Lockhart, Peter ^b   Pithie, Alan ^c   Bagg, Jeremy ^a,d  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CAROLINAS MEDICAL CENTER   (United States)

^c RUCHILL HOSPITAL   (United Kingdom)

^d GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; CANDIDA; CANDIDA ALBICANS; CD4 LYMPHOCYTE COUNT; CLASSIFICATION; COMPARATIVE STUDY; CULTURE MEDIUM; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MOUTH; PICHIA; THRUSH;

ADULT; AGAR; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CD4 LYMPHOCYTE COUNT; COLONY COUNT, MICROBIAL; CULTURE MEDIA; DRUG RESISTANCE, MICROBIAL; FEMALE; FLUCONAZOLE; HIV SEROPOSITIVITY; HUMANS; MALE; MOUTH; PICHIA;

EID: 0032059674     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(98)90291-8     Document Type: Article

References (27)

1. Greenspan JS, Greenspan D. Oral complications of HIV infection. In: Sande MA, Volberding PA, editors. The medical management of AIDS. 4th ed. Philadelphia: W.B. Saunders; 1995. p. 224-40.
2. Williams DM. EC-Clearinghouse on oral problems related to HIV-infections and WHO collaborating centre on oral manifestations of the immunodeficiency virus: classification and diagnosis criteria for oral lesions in HIV infection. J Oral Pathol Med 1993;22:289-91.
3. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988;239:617-22.
4. Reef SE, Mayer KH. Opportunistic Candidat infections in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis 1995;21:S99-102.
5. Greenspan D. Treatment of oral candidiasis in HIV infection. Oral Surg Oral Med Oral Pathol 1994;78:211-5.
6. Korting HC, Ollert M, Georgii A, Froschl M. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. J Clin Microbiol 1989;26:2626-31.
7. Goa KL, Barradell LB. Fluconazole: an update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. Drugs 1995;50:658-90.
8. De-Wit S, Weerts D, Goosens H, Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989;1:746-7.
9. Click M, editor. Clinician's guide to treatment of HIV-infected patients. The American Academy of Oral Medicine; 1996. p. 14.
10. Just-Nubling G, Gentschew G, Dohle M, Bottinger C, Helm EB, Stille W. Fluconazole in the treatment of ororpharyngeal candidosis in HIV-positive patients. Mycoses 1990;33:435-40.
11. Diz-Dios PD, Alvarez AJ, Fernandez FI, Castro FM. Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:170-4.
12. Nightingale SD, Pererson DM. Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS 1991;6:191-4.
13. Denning DW. Can we prevent azole resistance in fungi? [Commentary] Lancet 1995;346:454-5.
14. Fulton P, Philips P. Fluconazole resistance during suppressive therapy of AIDS-related thrush and oesophagitis caused by Candida albicans. International Conference on AIDS 1990;6: 239.
15. Pfaller MA, Rex JH, Rinaldi MG. Antifungal susceptibility testing: technical advances and potential clinical applications. Clin Infect Dis 1997;24:776-84.
16. Triollet N, Durussel C, Bille J, Glauser MP, Chave JP. Correlation between in vitro susceptibility of Candida albicans and fluconazole resistant oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1993;12:911-5.
17. Cameron ML, Schell WA, Bruch S, Bartlett JA, Waskin HA, Perfect JR. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of indi-viduals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother 1993;37:2449-53.
18. Law D, Moore CB, Wardle HM, Ganguli LA, Keany MGL, Denning DW. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 1994;34:659-88.
19. Goff DA, Koletar SL, Buesching WJ, Barnishan J, Fass RJ. Isolation of fluconazole resistant Candida albicans from human immunodeficiency virus negative patients never treated with azoles. Clin Infect Dis 1995;20:77-83.
20. Winguard JR, Merz WG, Rinaldi MG, Johnstone TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.
21. McCullough M, Hume S. A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV infected patients. J Med Vet Mycol 1995;33:33-7.
22. Quereda C, Polanco AM, Giner C, Sánchez-Sousa A, Pereira E, Navas E, et al. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1996;15: 30-7.
23. Warren NG, Shadony HJ. Yeasts of medical importance. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadony HJ, editors. Manual of clinical microbiology. 5th ed. Washington: American Society for Microbiology; 1993. p. 621-4.
24. Barry AL, Brown SD. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J Clin Microbiol 1996;34:2154-7.
25. Jackson MS, Bagg J, Wiggins A, Richardson M. Comparison of four assays for determining fluconazole-sensitivity of Candida albicans [abstract]. Br J Biomed Sci 1996;53:69.
26. Vuffray S, Durussel C, Boerlin P. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV infected patients. AIDS 1994;8:708-9.
27. Vartivatian S, Smith CB. Pathogenesis, host reponse, and predisposing factors. In: Bodey GP, editor. Candidiasis: pathogenesis, diagnosis and treatment. New York: Raven Press Ltd.; 1993. p. 59-84.